Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Parkinsonâs Disease Recent news which mentions Parkinson’s Disease Edward L. Weidenfeld, Reagan Attorney & DC Socialite Who Went From Capitol Hill To Cannabis Entrepreneur Dies At 79 January 10, 2023 Tags Parkinson’s Disease Markets Market News From Benzinga PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease September 17, 2022 Tickers PHRRF Tags Penny Stocks News Parkinson’s Disease From Benzinga AbbVie Walks Away From Parkinson's Drug Pact With BioArctic April 20, 2022 Tickers ABBV Tags News Large Cap Briefs From Benzinga Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program April 12, 2022 Tickers GANX Tags Benzinga Movers GANX From Benzinga Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs March 16, 2022 Tickers PRTA Tags Market News Preclinical Phase Parkinson’s Disease From Benzinga Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs March 15, 2022 Tickers GANX Tags Trading Ideas Penny Stocks Health Care From Benzinga 4D Pharma To Test Its Single-Strain Live Biotherapeutics In Parkinson's Disease February 22, 2022 Tickers LBPS Tags Health Care Trading Ideas Penny Stocks From Benzinga FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease January 25, 2022 Tickers ANVS Tags Health Care Trading Ideas News From Benzinga Yumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Disease January 19, 2022 Tickers YMTX Tags General FDA YMTX From Benzinga Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data November 10, 2021 Tickers YMTX Tags YMTX General Benzinga From Benzinga Why Did BioVie Shares Jump 21% Today? October 26, 2021 Tickers BIVI Tags General Phase 2 Trial Briefs From Benzinga EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo October 05, 2021 Tickers ANVS Tags Parkinson’s Disease Market News News From Benzinga Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate October 04, 2021 Tickers IKT Tags General Briefs Biotech From Benzinga Stealth Bio Posts Encouraging Preclinical Data In Parkinson's Animal Studies September 23, 2021 Tickers MITO Tags General Briefs MITO From Benzinga Gain Therapeutics' Gaucher, Parkinson's Candidate Shows Potential In Patient-Derived iPSC Study September 08, 2021 Tickers GANX Tags Market News Parkinson’s Disease Health Care From Benzinga Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial August 26, 2021 Tickers AMRX Tags Small Cap General Biotech From Benzinga AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration August 09, 2021 Tickers ABBV Tags General Contracts Market News From Benzinga Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis August 05, 2021 Tickers CLNN Tags Benzinga CLNN Biotech From Benzinga IBM, Michael J. Fox Foundation Using Artificial Intelligence To Fight Parkinson's Disease July 29, 2021 Tickers IBM TECH Tags Tech News IBM From Benzinga AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate July 27, 2021 Tickers ACIU BNTX Tags Benzinga Biotech Briefs From Benzinga Inhibikase To Start Testing Its Parkinson's Candidate In Patients July 26, 2021 Tickers IKT Tags Health Care Penny Stocks IKT From Benzinga Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med July 23, 2021 Tickers ACOR Tags Movers Biotech Benzinga From Benzinga Ipsen In-Licenses Parkinson's Candidate From IRLAB July 15, 2021 Tickers IPSEY Tags News Briefs Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.